14:01 EDT GeoVax sees Gedeptin technology as potentially applicable to any solid tumor
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOVX:
- GeoVax Labs Announces $6 Million Public Offering
- GeoVax’s EMA guidance provides clear pathway, says Alliance Global Partners
- Closing Bell Movers: Solar stocks fall on tax credit threat
- GeoVax Labs files to sell 6.15M common units
- GeoVax Labs receives favorable European regulatory guidance supporting GEO-MVA